Loading...
Please wait, while we are loading the content...
Similar Documents
Adjunctive benzodiazepine treatment of hospitalized schizophrenia patients in Asia from 2001 to 2008
| Content Provider | Scilit |
|---|---|
| Author | Tor, Phern-Chern Ng, Tze Pin Yong, Kian-Hui Sim, Kang Xiang, Yu-Tao Wang, Chuan-Yue Lee, Edwin Ho Ming Fujii, Senta Yang, Shu-Yu Chong, Mian-Yoon Ungvari, Gabor S. Si, Tianmei He, Yan Ling Chung, Eun Kee Chee, Kok-Yoon Trivedi, Jintendra Udomratn, Pichet Shinfuku, Naotaka Kua, Ee Heok Tan, Chay Hoon Sartorius, Norman Baldessarini, Ross J. |
| Copyright Year | 2011 |
| Description | Benzodiazepines are commonly prescribed to patients with schizophrenia in many countries, but as little is known about such treatment in Asia, we evaluated their adjunctive use for 6761 in-patients diagnosed with schizophrenia in nine Asian countries using a cross-sectional study design in 2001, 2004 and 2008. Multivariate logistic regression and multivariate linear regression analyses were performed to assess predictors of benzodiazepine use and dose, respectively. Overall, 54% of the patients received adjunctive benzodiazepines at an average daily dose equivalent to 30.3 mg diazepam, with minor changes over the years sampled. Benzodiazepine use was highest in Taiwan and Japan, lowest in Thailand and China, and was associated with fewer years ill, presence of delusions (OR 1.24), hallucinations (OR 1.22), disorganized speech (OR 1.17), social or occupational dysfunction (OR 1.16), and use of mood stabilizers (OR 3.15), antiparkinsonian (OR 1.79) or antidepressant drugs (OR 1.33), and lower doses of antipsychotics (all p=0.016 to <0.001). Benzodiazepine doses were highest in Taiwan and China, lowest in Korea and Singapore; higher doses were associated with being young, male, physically aggressive, receiving mood stabilizers, and having electroconvulsive treatment (all p=0.019 to <0.001). Benzodiazepine use was associated with neurological and systemic adverse effects. In conclusion, benzodiazepine use was common in Asian patients with schizophrenia. Predictors of benzodiazepine use and dose differed in this population. Critical clinical guidelines should be developed specifically for Asian countries to address sound practices in regard to use of benzodiazepines for psychotic disorders. |
| Related Links | https://core.ac.uk/download/pdf/37999644.pdf https://academic.oup.com/ijnp/article-pdf/14/6/735/2713448/14-6-735.pdf |
| Ending Page | 745 |
| Page Count | 11 |
| Starting Page | 735 |
| DOI | 10.1017/s146114571000163x |
| Journal | International Journal of Neuropsychopharmacology |
| Issue Number | 6 |
| Volume Number | 14 |
| Language | English |
| Publisher | Cambridge University Press (CUP) |
| Publisher Date | 2011-02-04 |
| Access Restriction | Open |
| Subject Keyword | International Journal of Neuropsychopharmacology Psychiatry and Mental Health Benzodiazepine Use Patients with Schizophrenia |
| Content Type | Text |
| Resource Type | Article |
